Show results for
Refine by
Locations
- Europe
- Albania
- Andorra
- Austria
- Belarus
- Belgium
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Kosovo
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Montenegro
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Vatican City
Neurology Disease Suppliers In Europe
23 companies found
based inSchlangenbad, GERMANY
DIERS International GmbH was founded in Wiesbaden in 1996. The company founder, Dipl. Eng. Helmut Diers, first completed an international career with various globally operating medical technology companies. From the beginning, close scientific ...
based inWarszawa, POLAND
TeleNeuroforma is based on 8 years of experience. The exercises used in Neuroforma have already proven themselves in stationary rehabilitation. Hundreds of facilities use the Neuroforma PRO station every day, and thousands of patients have already ...
Practice wherever and whenever you want: Do you want to start home rehabilitation? Just go to the website app.neuroforma.pl, register and you’re done! You can use Neuroforma on your computer or tablet. For exercise, you need an Internet ...
based inBlankenfelde-Mahlow, GERMANY
Medipan GmbH was founded in 1992 and is an independent, family company. The company started with the marketing of radioimmunoassays for the characterization of thyroid function, disease and tumor markers, with its partners from nuclear medicine ...
based inLeiden, NETHERLANDS
A leading pioneer in leveraging iPSC innovation for drug discovery. The catalyst with the requisite iPSC know-how and experience to empower innovators in drug discovery to advance their science relentlessly, consistently and efficiently. For the ...
based inUppsala, SWEDEN
Olink Proteomics is a Swedish company dedicated to innovation, quality, rigor and transparency, providing outstanding products and services for human protein biomarker discovery. Our groundbreaking Olink panels for precision proteomics help ...
Olink Target 48 Cytokine is the ultimate solution for cytokine studies and inflammation-related diseases. The thorough selection of biomarkers ensures that the most important proteins covering key pathways related to cytokine signaling and ...
based inHeidelberg, GERMANY
Molecular Health is an international biotech IT company based in Heidelberg, Germany, that has been developing innovative software in the areas of in silico and precision medicine since 2004. Molecular Health’s solutions make it possible to ...
based inRivas-Vaciamadrid, SPAIN
Marsi Bionics (Marsi) is an SME founded in 2013 as a spin-off from the Centro de Automática y Robótica (CAR), a joint centre of the Universidad Politécnica de Madrid (UPM) and the Spanish National Research Council (CSIC). Since 2019 the CSIC is part ...
Such a multidisciplinary public-private partnership will offer the most reliable diagnosis and innovative therapies for neurological diseases. In addition, research will allow the use of technology to be extended to ...
based inWroclaw, POLAND
Pure Biologics is a biopharmaceutical company focused on the biological drug and non-systemic therapies discovery and development. We operate in the areas of immuno-oncology, autoimmunology, and rare neurological diseases, conducting research based ...
Neuromyelitis optica (NMO) is an neurological autoimmune condition classified as a rare disease. Because of this classification, NMO lacks effective treatment options, since it is not of primary interest to the ...
based inRueil-Malmaison Cedex, FRANCE
At Advanced Accelerator Applications (AAA), we are reimagining nuclear medicine and cancer care. Our mission is to transform patients’ lives by developing and delivering targeted radioligand therapies and precision imaging radioligands for oncology. ...
AAA brand names for FDG (most widely used PET tracer): Oncology, cardiology, neurology. Infectious and inflammatory ...
based inDerio, SPAIN
Innoprot is a company specializing in the development and provision of high-quality cell lines and assays for use in research and drug discovery. They offer a wide array of G protein-coupled receptor (GPCR) cell lines, which are essential for ...
based inTägerwilen, SWITZERLAND
STORZ MEDICAL AG, founded in 1987, is an independent partner company of the KARL STORZ Group. We are a medical technology manufacturer located in the heart of Europe, on the Swiss shore of Lake Constance in Tägerwilen, and we develop innovative ...
based inLondon, UNITED KINGDOM
Epsy is a leading digital health platform empowering patients, caregivers and healthcare providers with a better way to live with seizures and epilepsy. A monumental, yet rewarding mission, as epilepsy is one of the most common neurological diseases ...
based inLublin, POLAND
We are a Polish biotechnology company with long manufacturing traditions. We have been present on the Polish and international markets since 1944. We are challenged and truly honoured to provide the leading, innovative medical solutions, and, due to ...
based inBerlin, GERMANY
Good diagnostic products require high-quality human biomaterials (serums, standards, control samples, purified proteins, and antibodies). Out of this need, we founded ourselves in 1997 as a spin-off of the research department of B.R.A.H.M.S. AG. ...
Our panels, pools and individual donations from normal donors are designed for the use throughout the whole value chain of in-vitro diagnostics. Due to their high quality and defined specifications, they are suitable for use in research and ...
based inBrisbane, CALIFORNIA (USA)
Sangamo is a genomic medicine company that seeks to help millions of people who suffer from severe diseases for which today’s medicine can only offer symptom management at best. Our mission is to translate ground-breaking science into medicines that ...
Sangamo’s proprietary zinc finger (ZF) platform uniquely confers a number of advantages and has broad therapeutic potential due to its versatility, specificity and clinical utility. Zinc finger technologies are composed of a DNA-binding ...
based inFreiburg, GERMANY
We are providing tomorrows solutions in neurotechnology already today. We are creating new ways of communication between electrical signals of the body and modern information technology. Our technology enables our partners and customers to develop ...
based inBallymena, NORTHERN IRELAND
Neurovalens has designed cranial nerve stimulation technology that accurately and efficiently activates key brainstem neurons without needing implanted electrodes. This non-invasive approach removes the need for surgical implantation and allows much ...
We believe in people and their ability to improve their lives for the ...
based inCAEN, FRANCE
Lys Therapeutics, first-in-class biotherapies against neurological diseases. Lys Therapeutics is a French biotech company developing innovative drugs to treat patients suffering from neurovascular or neurodegenerative disorders, including stroke and ...
Glunomab / Glunozumab®: a monoclonal antibody counteracting the strong toxicity triggered by the interaction of an endogenous protease, tissue plasminogen activator (tPA) with NMDA receptors ...
based inShirley, NEW YORK (USA)
After decades of research and accumulation, Creative Biolabs has become a leader in the discovery and manufacturing of recombinant antibodies (rAbs), providing the most reliable and qualified services to customers in academia and industry around the ...
Biological drugs are macromolecules manufactured in, extracted from or semi synthesized by modern biotechnological methods within a living organism and can be composed of sugars, proteins, nucleic acids or complex combinations of these substances, ...
based inViken, SWEDEN
TIKOMED AB is a privately owned company based in Viken, Sweden. It is governed by the Laws of the Kingdom of Sweden and was formed in accordance with the Swedish Company Act in 2002. We develop and commercialize innovative treatments for patients ...
